Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

Files

hdl_140154.pdf (226.34 KB)
  (Published version)

Date

2021

Authors

Tabiri, S.
Kamarajah, S.K.
Nepogodiev, D.
Li, E.
Simoes, J.
Sravanam, S.
Owusu, S.A.
Mahama, H.
Agyeman, Y.N.
Arthur, J.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

BJS Open, 2021; 5(6)

Statement of Responsibility

COVIDSurg Collaborative, Stephen Tabiri ... Royal Adelaide Hospital, Australia, DudiVenkata NN ... Kroon HM ... Sammour T ... et al.

Conference Name

Abstract

There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© The Author(s) 2022. Published by Oxford University Press on behalf of BJS Society Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

License

Grant ID

Call number

Persistent link to this record